(877) 320-5131 Menu
(877) 320-5131
Contact
Patient Portal

Upcoming

Pfizer: (EZH2): 235999: A PHASE I DOSE ESCALATION AND EXPANDED COHORT STUDY OF PF-06821497 IN THE TREATMENT OF ADULT PATIENTS WITHRELAPSED/REFRACTORY SMALL CELL LUNG CANCER (SCLC), CASTRATION RESISTANT PROSTATE CANCER (CRPC) AND FOLLICULARLYMPHOMA (FL):


A Phase II/III, Randomised, Multicentre Study of MOR00208 with Bendamustine versus Rituximab with Bendamustine in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R-R DLBCL) Who Are Not Eligible for High-Dose Chemotherapy (HDC) and Autologous Stem-Cell Transplantation (ASCT) – B-MIND

Schedule a Consultation

Your health is important, and we welcome the opportunity to help you heal.


To schedule an appointment, please call Beverly Hills Cancer Center in Beverly Hills, California at (877) 320-5131 or Click the link below to access our Online Appointment Request

Book An Appointment

© Beverly Hills Cancer Center. All Rights Reserved. Web Design & Internet Marketing by Studio III

Privacy Policy

Rate Us
Rate us on Google Rate us on Yelp Rate us on HealthGrades Rate us on Facebook Rate us on Yahoo! Rate us on WebMD
Contact Us